NCT06042192View on ClinicalTrials.gov

Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

November 9, 2023

Study Completion Date

December 13, 2023

Conditions
Healthy
Interventions
DRUG

TK-254RX

Two TK-254RX per day to predetermined application site

Trial Locations (4)

Unknown

Medical Practice Ebert, Brühl

Medical practice Pabst, Fürstenfeldbruck

Medical practice Gastl, Gilching

Medical Pracitice Schaale/Bücheler, Rheinbach

Sponsors

Collaborators (1)

ClinSearch
All Listed Sponsors
collaborator

ClinSearch

OTHER

collaborator

SocraTec R&D GmbH

OTHER

collaborator

SocraMetrics GmbH

INDUSTRY

collaborator

CRM Biometrics GmbH

INDUSTRY

collaborator

Clinigen Clinical Supplies Management GmbH

UNKNOWN

lead

Teikoku Seiyaku Co., Ltd.

INDUSTRY

NCT06042192 - Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers. | Biotech Hunter | Biotech Hunter